• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中与免疫丙酸代谢相关的生物标志物的鉴定

Identification of biomarkers associated with immune-propionate metabolism in nonalcoholic fatty liver disease.

作者信息

Qu Shuye, Huang Hui, Diao Yan, Liu Bowei, Tang Baozhu, Huo Shijiao, Lei Yu, Xuan Xiuchen, Mou Wenling, Liu Ping, Zhang Jiye, Liu Ying, Li Yanze

机构信息

Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China.

Department of Gastroenterology, Heilongjiang Provincial Hospital, Harbin, China.

出版信息

Cell Mol Biol (Noisy-le-grand). 2023 Oct 31;69(10):254-263. doi: 10.14715/cmb/2023.69.10.38.

DOI:10.14715/cmb/2023.69.10.38
PMID:37953553
Abstract

The mechanisms of the effect of propionate metabolism and immunity on nonalcoholic fatty liver disease (NAFLD) have not been adequately studied. Firstly, differentially expressed-propionate metabolism-related genes (DE-PMRGs) were selected by overlapping PMRGs and differentially expressed genes (DEGs) between the simple steatosis (SS) and health control (HC) groups. Then, common genes were selected by overlapping DE-PMRGs and key module genes obtained from weighted gene co-expression network analysis (WGCNA). Subsequently, the biomarkers were screened out by machine learning algorithms. The expression of the biomarkers was validated by quantitative Real-time PCR. In total, 5 biomarkers (JUN, LDLR, CXCR4, NNMT, and ANXA1) were acquired. The nomogram constructed based on 5 biomarkers had good predictive power for the risk of SS. Next, 5 biomarkers, 11 miRNAs, and 149 lncRNAs were encompassed in the ceRNA regulatory network. The expression of biomarkers was significantly higher in the HC group than in the SS group, which was consistent with the results in the GSE89632 and GSE126848 datasets. In this study, 5 immune and propionate metabolism-related biomarkers (JUN, LDLR, CXCR4, NNMT, and ANXA1) were screened out to provide a basis for exploring the prediction of diagnosis of NAFLD.

摘要

丙酸代谢与免疫对非酒精性脂肪性肝病(NAFLD)影响的机制尚未得到充分研究。首先,通过重叠单纯性脂肪变性(SS)组与健康对照组(HC)之间的丙酸代谢相关基因(PMRGs)和差异表达基因(DEGs),筛选出差异表达的丙酸代谢相关基因(DE-PMRGs)。然后,通过重叠DE-PMRGs与从加权基因共表达网络分析(WGCNA)获得的关键模块基因,筛选出共同基因。随后,通过机器学习算法筛选出生物标志物。通过定量实时PCR验证生物标志物的表达。总共获得了5个生物标志物(JUN、LDLR、CXCR4、NNMT和ANXA1)。基于这5个生物标志物构建的列线图对SS风险具有良好的预测能力。接下来,ceRNA调控网络纳入了5个生物标志物、11个miRNA和149个lncRNA。生物标志物在HC组中的表达显著高于SS组,这与GSE89632和GSE126848数据集中的结果一致。在本研究中,筛选出5个免疫和丙酸代谢相关生物标志物(JUN、LDLR、CXCR4、NNMT和ANXA1),为探索NAFLD诊断预测提供依据。

相似文献

1
Identification of biomarkers associated with immune-propionate metabolism in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中与免疫丙酸代谢相关的生物标志物的鉴定
Cell Mol Biol (Noisy-le-grand). 2023 Oct 31;69(10):254-263. doi: 10.14715/cmb/2023.69.10.38.
2
Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease.鉴定与非酒精性脂肪性肝病相关的代谢生物标志物。
Lipids Health Dis. 2023 Sep 11;22(1):150. doi: 10.1186/s12944-023-01911-2.
3
Diagnostic value of sphingolipid metabolism-related genes CD37 and CXCL9 in nonalcoholic fatty liver disease.鞘脂代谢相关基因 CD37 和 CXCL9 对非酒精性脂肪性肝病的诊断价值。
Medicine (Baltimore). 2024 Feb 23;103(8):e37185. doi: 10.1097/MD.0000000000037185.
4
Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.整合生物信息学和机器学习筛选免疫相关基因,用于诊断非酒精性脂肪肝合并缺血性脑卒中及 RRS1 泛癌分析。
Front Immunol. 2023 Apr 5;14:1113634. doi: 10.3389/fimmu.2023.1113634. eCollection 2023.
5
Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.免疫相关基因在非酒精性脂肪性肝病不同阶段的表达及可能的调控机制。
Front Immunol. 2024 Mar 8;15:1364442. doi: 10.3389/fimmu.2024.1364442. eCollection 2024.
6
Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.通过机器学习算法鉴定非酒精性脂肪肝和阿尔茨海默病的诊断基因特征和分子机制。
Clin Chim Acta. 2024 Apr 15;557:117892. doi: 10.1016/j.cca.2024.117892. Epub 2024 Mar 26.
7
Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.通过生物信息学和实验分析鉴定核糖体蛋白家族作为 NAFLD 的免疫细胞相关生物标志物。
Front Endocrinol (Lausanne). 2023 May 19;14:1161269. doi: 10.3389/fendo.2023.1161269. eCollection 2023.
8
Dynamic co-expression modular network analysis in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的动态共表达模块网络分析。
Hereditas. 2021 Aug 21;158(1):31. doi: 10.1186/s41065-021-00196-8.
9
Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.基于生物信息学分析和机器学习的非酒精性脂肪性肝病(NAFLD)合并慢性肾脏病(CKD)诊断生物标志物的鉴定。
Front Endocrinol (Lausanne). 2023 Feb 27;14:1125829. doi: 10.3389/fendo.2023.1125829. eCollection 2023.
10
Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.生物信息学分析揭示了与非酒精性脂肪性肝病和非酒精性脂肪性肝炎相关的新核心基因。
Gene. 2020 Jun 5;742:144549. doi: 10.1016/j.gene.2020.144549. Epub 2020 Mar 14.

引用本文的文献

1
The Role of miRNAs and Epigenetic Factors in Non-Alcoholic Fatty Liver Disease - a Systematic Review.微小RNA和表观遗传因素在非酒精性脂肪性肝病中的作用——一项系统综述
Curr Health Sci J. 2025 Jan-Mar;51(1):37-52. doi: 10.12865/CHSJ.51.01.04. Epub 2025 Mar 31.
2
Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.免疫相关基因在非酒精性脂肪性肝病不同阶段的表达及可能的调控机制。
Front Immunol. 2024 Mar 8;15:1364442. doi: 10.3389/fimmu.2024.1364442. eCollection 2024.